Facilitative effect of a glutamate transporter inhibitor (2S,3S)-3-{3-[4-(trifluoromethyl)benzoylamino]benzyloxy}aspartate on the expression of methamphetamine-induced behavioral sensitization in rats

Journal of Pharmacological Sciences

Volumn 99, Issue 4, 2005, Pages 415-418

  Fujio, Mayumi ^a   Nakagawa, Takayuki ^a   Suzuki, Yuichi ^a   Satoh, Masamichi ^b   Kaneko, Shuji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Glutamate transporter; Methamphetamine; Sensitization

Indexed keywords

(2S,3S) 3 [3 [4 (TRIFLUOROMETHYL)BENZOYLAMINO]BENZYLOXY]ASPARTATE; ASPARTIC ACID DERIVATIVE; GLUTAMATE TRANSPORTER; METHAMPHETAMINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BEHAVIORAL SENSITIZATION; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; HYPERACTIVITY; IRRITABILITY; LOCOMOTION; NONHUMAN; PROVOCATION TEST; RAT; REGULATORY MECHANISM; SENSITIZATION;

EID: 29144524609     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.SC0050144     Document Type: Article

References (15)

1. Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 2000;151:99-120.
2. Robinson MB. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem Int. 1999;33:479-491.
3. Shirai Y, Shirakawa O, Nishino N, Saito N, Nakai H. Increased striatal glutamate transporters by repeated intermittent administration of methamphetamine. Psychiat Clin Neurosci. 1996;50:161-164.
4. Ozawa T, Nakagawa T, Shige K, Minami M, Satoh M. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res. 2001;905:254-258.
5. Abekawa T, Honda M, Ito K, Inoue T, Koyama T. Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine. Psychopharmacology. 2002;160:122-131.
6. Nakagawa T, Fujio M, Ozawa T, Minami M, Satoh M. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res. 2005;156:233-239.
7. Sekiya Y, Nakagawa T, Ozawa T, Minami M, Satoh M. Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-β-benzyloxyaspartate in rats. Eur J Pharmacol. 2004;485:201-210.
8. Shimamoto K, Sakai R, Takaoka K, Yumoto N, Nakajima T, Amara SG, et al. Characterization of novel L-threo-β-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol Pharmacol. 2004;65:1008-1015.
9. Bespalov AY, Zvartau EE. Intraaccumbens administration of NMDA receptor antagonist (±)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats. Pharmacol Biochem Behav. 1996;55:203-207.
10. Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M, et al. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci. In press.
11. Kalivas PW, Duffy P, Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther. 1989;251:378-387.
12. Donzanti BA, Uretsky NJ. Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: possible dependence on dopaminergic mechanisms. Neuropharmacology. 1983;22:971-981.
13. Del Arco A, Gonzalez-Mora JL, Armas VR, Mora F. Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms. Neuropharmacology. 1999;38:943-954.
14. 1 dopamine receptor agonist when glutamate reuptake is inhibited. J Neurosci. 2001;21:RC133.
15. Aked J, Coizet V, Clark D, Overton PG. Local injection of a glutamate uptake inhibitor into the ventral tegmental area produces sensitization to the behavioural effects of d-amphetamine. Neuroscience. 2005;134:361-367.